AQST在收到FDA拒信以后也被移除出这个表单,现在FDA催化剂是收到批准不咋涨,收到拒信一定大跌。不过公司明年还有一个药物需要批准,应该还有翻身的机会。<...查看全文
$Eton Pharmaceuticals(ETON)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-24-015697 Act: 34 Size: 4 MB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-24-015686 Act: 34 Size: 301 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-24-013838 Act: 34 Size: 170 KB 网页链接
$Eton Pharmaceuticals(ETON)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001493152-24-017144 Act: 34 Size: 45 KB 网页链接
$Eton Pharmaceuticals(ETON)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-24-013429 Act: 34 Size: 1 MB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, item 3.02 Accession Number: 0001437749-24-012443 Act: 34 Size: 156 KB 网页链接
$Eton Pharmaceuticals(ETON)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001437749-24-009421 Act: 33 Size: 77 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-24-009052 Act: 34 Size: 270 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-24-008919 Act: 34 Size: 185 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-24-007853 Act: 34 Size: 6 MB 网页链接